Want to join the conversation?
Thousand Oaks, California-based $AMGN said in total it is expecting on the order of 80 new launches across its countries and products in 2016. Repatha is launching now in Japan, Brazil and multiple countries in Europe and the early signs are good. Kyprolis is off to a strong early start in its first markets in Europe.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.